Jun
8
2022
Upcoming webinar

Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Wednesday June 8th 2022 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

In this webinar, you will learn about cutting-edge organ chip technology already in use by several of the top pharmaceutical companies for drug development and immuno-oncology applications. Most cells in our body are no farther from a blood vessel than the width of a hair. Blood vessels help pattern tissues and provide them with their nutrients, and since almost all therapeutics — whether small molecules, antibodies, or leukocytes — reach our tissues via blood vessels, no model of tissue-drug interaction is realistic without this supporting vascular network. You will learn what readouts are available in vitro for developing drug, cell and gene-based therapies, including:

  • Continual imaging of tumor growth and response to drugs
  • Imaging of leukocyte vascular adhesion & extravasation
  • Assessment of tumor occupancy and killing by leukocytes, including CAR-Ts
  • Assessment of monoclonal antibody & bispecific delivery and efficacy
  • Assessment of target gene expression by in situ staining or qPCR
  • Collection of venous outflow for assessment of biomarkers

Attend this webinar to learn:

  • How responses in Vascularized Micro-Tumor chips compare to responses seen in patient tumors
  • What types of drug, cell-based and gene therapy studies can be conducted using Vascularized-Micro Tumor chips
  • How Vascularized Micro-Tumor chips compare to other models, such as 2D cell culture or spheroid models

Dr Chris Hughes

CSO, Aracari Biosciences

Dr. Hughes is a professor in the Departments of Molecular Biology & Biochemistry and Biomedical Engineering at UC Irvine. His recent appointments have included Department Chair, Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology, and co-director of the Onco-Imaging and Biotechnology (OIB) Program, part of the Chao Family Comprehensive Cancer Center at UCI. The work in his lab spans multiple scales – from understanding the basic molecular mechanisms of angiogenesis (the growth of new blood vessels), to engineering of artificial tissues. Recently his lab has been pioneering “Body-on-Chip” technology, which allows for human micro-organs – heart, pancreas, tumor, etc. – to be grown in the lab with their own blood vessel network.

22
Days
8
Hrs
54
Min

SPEAKERS

Chris Hughes
CSO at Aracari Biosciences

You might also like

Accelerating cell therapy discovery & development with non-viral gene...

D Hermanson
X Patrinostro
David Hermanson
David Hermanson
Senior Manager of R&D Applications, Cell and Gene Therapy at Bio-techne
Xiaobai Patrinostro
Xiaobai Patrinostro
Manager of Genome Engineering Services, Cell and Gene Therapy at Bio-techne
16 Jun 2022
29
Days
16
Hrs
54
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
14
Days
8
Hrs
54
Min
Register

Discovery to manufacturing: A continuum

A Chang,
T Hitchcock,
B Fry
Audrey Chang
Audrey Chang
Executive Director Quality Control & Analytical Sciences at Charles River Laboratories
Tony Hitchcock
Tony Hitchcock
Technical Director at Charles River Laboratories, Inc
Brian Fry
Brian Fry
Director, Sales - Biologics at Charles River Laboratories
5 April 2022
Watch now

Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

M Hewitt
Matt Hewitt, PhD
Matt Hewitt, PhD
Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
11 January 2022
Watch now

Advancing engineered cell and gene therapy with precision gene editing

D Maddalo
Danilo Maddalo
Danilo Maddalo
Group Leader, Translational Oncology, Genentech
11 November 2021
Watch now